In 2021, Escagedo et al. [13] introduced the importance of evaluating IGF1-SDS to distinguish between progressive forms of CPP and isolated premature adrenarche/precocious thelarche in girls aged 6–8 years whenever the initial clinical and laboratory approach was inconclusive. The gene discussed is IGF1; the disease is central precocious puberty.